Archives by Month:
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- January 2024
- December 2023
- November 2023
- October 2023
- August 2023
- July 2023
- June 2023
- May 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- July 2016
- June 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- November 2012
- October 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- June 2009
- April 2009
- February 2009
- December 2008
- November 2008
- October 2008
- August 2008
- June 2008
- May 2008
Archives by Year:
Union Pacific Q1 Revenue Up 6.3% As Coal Shipments Surge
Union Pacific Corporation (NYSE: UNP) early Thursday posted market-beating first quarter earnings results, with a big increase in coal shipments leading the way higher.
Draghi Does Nothing And Talks About It
As widely expected, the ECB left its key rates and asset purchase plan intact. It reiterated its forward guidance that rates will remain at present levels or lower. Draghi was more confident about the economy, suggesting that the downside risks had further diminished. They are more closely to balanced, which sets up the potential […]
Big Is Never Big Enough
The biggest, best, massive tax cut plan in all human history was not enough to shake the petroleum sector out of its bearish slumber. The petroleum sector has been dripping down slowly like a good old fashion water torture as the market is fixated on short-term supplies and not our future. While the market continues […]
E NZDUSD Intraday Drop
NZDUSD is falling sharply, probably because wave four found a top and current drop may be the start of final wave five. That said, the price may see some support and limited downside around the 0.6849 region where wave one would equal wave five, or if price continues beneath this level around the 261.8 Fibonacci […]
Celgene Beats On Q1 Earnings, Misses On Sales
Summit, NJ based Celgene Corporation (CELG – Free Report) is a biopharmaceutical company focused on the discovery, development and commercialization of drugs targeting cancer and inflammatory diseases. Celgene’s key growth driver is Revlimid. The company’s portfolio also includes Pomalyst/Imnovid, Abraxane, Otezla, Istodax, Vidaza and Thalomid/Thalidomide. However, Celgene is facing generic competition for Vidaza. In this scenario, investor focus remains […]
The Most Hated Bull Market In History: Update
The PM complex has been taking up most of my time the last couple of weeks so tonight I would like to update you on some of the stock market indexes. No matter how one wants to spin it the US stock markets have been in a bull market since 2009 by any trading discipline. […]
E China Yields To Trump; Putin Pushes
While the relief rally in France over Macron’s lead continues, there is reason for caution. Leftist candidate Mélanchon is refusing to back the former Rothschild banker against Marine Le Pen, the anti-immigrant right-wing populist. And once again, according to both Macron’s En Marche movement and Japanese counter-espionage trackers, Vladimir Putin’s pirates are trying to hack into the […]
No Reasonable Retracement In Equities Yet: S&P 500 And CAC 40 Outlook
Since the Q4 of last year until today, we haven’t seen a reasonable retracement in global equities, especially in the US equities. For the past few weeks, S&P 500 and DowJones had a slight retracement to the downside, which did not exceed 3%. This was right before the French election, which was considered as the […]
Domino’s Pizza Comps Skyrocket As Q1 Earnings Top Expectations
Written by StockNews.com Domino’s Pizza, Inc. (NYSE: DPZ) early Thursday posted much better than expected first quarter earnings results, as sales at established stores surged from last year.
UPS Shares Rise On Earnings Beat, Sirius XM Holdings Inc. Falls On In-Line Results
UPS (UPS) and Sirius XM (SIRI) released their latest earnings reports before opening bell this morning. UPS reported earnings of $1.32 per share on $15.3 billion in revenue, against the Wall Street consensus estimates of $1.29 per share and $15.2 billion. In last year’s first quarter, the shipping company reported $1.27 per share in earnings […]
